Empagliflozin Ameliorates Diabetic Cardiomyopathy via Attenuating Oxidative Stress and Improving Mitochondrial Function
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin Ameliorates Diabetic Cardiomyopathy via Attenuating Oxidative Stress and Improving Mitochondrial Function
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2022, Issue -, Pages 1-16
Publisher
Hindawi Limited
Online
2022-05-10
DOI
10.1155/2022/1122494
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of empagliflozin in different phases of diabetes mellitus-related cardiomyopathy: a prospective observational study
- (2021) Satoshi Oka et al. BMC Cardiovascular Disorders
- The Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging
- (2021) Chao Yu et al. Oxidative Medicine and Cellular Longevity
- Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
- (2020) Yi Tan et al. Nature Reviews Cardiology
- The roles of resveratrol on cardiac mitochondrial function in cardiac diseases
- (2020) Apiwan Arinno et al. EUROPEAN JOURNAL OF NUTRITION
- Reciprocal Regulation of Mitochondrial Fission and Fusion
- (2020) Rasha Sabouny et al. TRENDS IN BIOCHEMICAL SCIENCES
- Empagliflozin improves left ventricular diastolic function of db/db mice
- (2020) Julia Moellmann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Activating AMP‐activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection from Nonalcoholic Fatty Liver Disease in Mice
- (2020) Qian Lin et al. HEPATOLOGY
- The Role of the Nrf2 Signaling in Obesity and Insulin Resistance
- (2020) Shiri Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways
- (2020) Raquibul Hasan et al. Scientific Reports
- Procyanidin B2 improves endothelial progenitor cell function and promotes wound healing in diabetic mice via activating Nrf2
- (2020) Jiawei Fan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Diabetic Cardiomyopathy
- (2019) Wolfgang H. Dillmann CIRCULATION RESEARCH
- Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice
- (2019) Mei Xue et al. CLINICAL SCIENCE
- Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy
- (2019) Isabella Evangelista et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up
- (2019) Peter D. Reaven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function
- (2019) Xiaozhen Dai et al. TRENDS IN MOLECULAR MEDICINE
- Clusterin ameliorates endothelial dysfunction in diabetes by suppressing mitochondrial fragmentation
- (2019) Lulu Ren et al. FREE RADICAL BIOLOGY AND MEDICINE
- Differential regulation of Nrf2 is linked to elevated inflammation and nitrative stress in monocytes of children with autism
- (2019) Ahmed Nadeem et al. PSYCHONEUROENDOCRINOLOGY
- Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
- (2018) Sarayut Lahnwong et al. Cardiovascular Diabetology
- Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus
- (2018) Xavier Palomer et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease
- (2018) Farzaneh G. Tahrir et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts
- (2017) Tsung-Ming Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting
- (2017) Adam J Wilson et al. HEART
- Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes
- (2017) Dajun Zhao et al. Oxidative Medicine and Cellular Longevity
- SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice
- (2017) Sai Ma et al. Oxidative Medicine and Cellular Longevity
- Effects of Polyphenols on Oxidative Stress-Mediated Injury in Cardiomyocytes
- (2017) Rosanna Mattera et al. Nutrients
- The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
- (2017) Joshua A. David et al. Journal of Diabetes Research
- The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
- (2017) Sebastian Steven et al. Redox Biology
- Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications
- (2017) Susana Rovira-Llopis et al. Redox Biology
- Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes
- (2016) Giuseppe Daniele et al. DIABETES CARE
- PHLPP2 down regulation influences nuclear Nrf2 stability via Akt-1/Gsk3β/Fyn kinase axis in acetaminophen induced oxidative renal toxicity: Protection accorded by morin
- (2016) Alpana Mathur et al. FOOD AND CHEMICAL TOXICOLOGY
- Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy
- (2016) Rui Ni et al. FREE RADICAL BIOLOGY AND MEDICINE
- Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
- (2016) Maximilian Hölscher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Diabetes mellitus statistics on prevalence and mortality: facts and fallacies
- (2016) Paul Zimmet et al. Nature Reviews Endocrinology
- Mitochondrial Dynamics in Diabetic Cardiomyopathy
- (2015) Chad A. Galloway et al. ANTIOXIDANTS & REDOX SIGNALING
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reactive oxygen species and excitation–contraction coupling in the context of cardiac pathology
- (2014) Anne C. Köhler et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Localizations of Na+-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart
- (2014) Ivana Vrhovac et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Diabetic cardiomyopathy
- (2012) BR Goyal et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members
- (2010) Jian Chen et al. Diabetes Therapy
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started